| Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis (NCT05441488) | AB Science | 2022-06-28 |
| Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis (NCT05706220) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2022-06-13 |
| Multiple Sclerosis Prediction and Monitoring of Progression Study (NCT05685784) | University Hospital, Ghent | 2022-03-01 |
| Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis (NCT04749667) | Haukeland University Hospital | 2021-08-09 |
| ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis (NCT04695080) | Queen Mary University of London | 2021-06-25 |
| Effect of Variance on Error Correction During Coupling (NCT04856384) | Hasselt University | 2021-02-01 |
| Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis (NCT04201470) | University Hospital, Montpellier | 2019-12-09 |
| Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis (NCT04120675) | Aristotle University Of Thessaloniki | 2018-11-09 |
| A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis (NCT03423121) | Johns Hopkins University | 2018-06-19 |
| Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis (NCT03493841) | Rebecca Spain | 2018-06-08 |
| Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis (NCT03552211) | University Hospital, Clermont-Ferrand | 2018-05-30 |
| Neural Stem Cell Transplantation in Multiple Sclerosis Patients (NCT03269071) | IRCCS San Raffaele | 2017-05-17 |
| G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis (NCT03980145) | Indiana University | 2017-05-02 |
| A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (NCT02977533) | Sanofi | 2016-12-01 |
| A Study of Oxidative Pathways in MS Fatigue (NCT02804594) | University of California, San Francisco | 2016-10-01 |
| A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis (NCT02583594) | Genzyme, a Sanofi Company | 2015-12-06 |
| A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 (NCT02313285) | Genzyme, a Sanofi Company | 2015-01-12 |
| A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (NCT02282826) | Genzyme, a Sanofi Company | 2014-10-01 |
| Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis (NCT02580669) | University Hospital, Montpellier | 2014-06-16 |
| Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (NCT01815632) | North Bristol NHS Trust | 2014-01-01 |
| Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis (NCT01305837) | Rigshospitalet, Denmark | 2011-04-01 |
| Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica (NCT01364246) | Shenzhen Beike Bio-Technology Co., Ltd. | 2010-01-01 |